Blood gas analyzer is a standard clinical diagnostic test machine used to measures a patient’s blood gases including oxygen and carbon dioxide and pH level. Arterial blood is the sample type required for correct assessment of gas exchange and function of lungs, specifically oxygenation status. Arterial blood pH is included in these measurements as dissolved carbon dioxide balances the acidity or alkalinity in the respiratory system.
Increasing number of patients being treated in ICUs, NICUs, and emergency departments is propelling demand for blood gas analyzers. According to a NCBI report of 2017, in England, emergency services demand has increased by 125%, from around 4 million calls in 1994 and 1995 to 9 million ambulance calls in 2014 and 2015. Moreover, increasing number of patients suffering from chronic diseases such as cancer, cardiovascular disease, and lung disease also require blood gas testing. According to American Heart Association 2016 report, cardiovascular diseases are the leading cause of death worldwide, accounting for around 17.3 million deaths annually and is expected to reach over 23.6 million by 2030.
Increasing demand for point of care testing is expected to drive the blood gas analyzers market revenue
Blood gas analyzers are used for patients suffering from certain medical conditions, including asthma and Chronic Obstructive Pulmonary Disease (COPD). Emergency and intensive care departments also use blood gas analyzers as crucial part for assessment of patient’s clinical status.
Increasing geriatric population at high risk of various chronic diseases, which require frequent testing of blood gas and Point-of-Care (PoC) diagnostic evaluation is expected to drive growth of the global blood gas analyzer market. According to the U.S. Census Bureau, 2015, population of age 65 years and above is expected to increase over 60% during 2015 – 2030. Moreover, increasing number of patients being treated in ICUs and emergency departments is also expected to fuel the market growth. According to the WHO, in 2015, around three million deaths were caused by chronic diseases, which accounted for 5% of all the deaths worldwide. This in turn led to significant increase in emergency cases demanding for blood gas analyzers.
Ask For Discount Before Purchasing This Business Report @ https://www.coherentmarketinsights.com/insight/request-discount/2603
Blood Gas Analyzers Market Restraints
High probability of infections through use of blood gas analyzers that are affected with patient acquired infections such as blood-borne pathogens during testing procedures is expected to hinder growth of the market. Blood gas analyzers can be difficult to use and therefore, require trained laboratory personnel. Moreover, collection of arterial blood is more difficult than venous or capillary blood sample. It is more painful for the patient and can be potentially dangerous, in case the correct procedure is not followed. All these factors are expected to negatively impact adoption of blood gas analyzers during the forecast period.
Blood Gas Analyzers Market - Regional Insights
On the basis of region, the global blood gas analyzers market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America blood gas analyzers market is expected to generate significant revenue share during the forecast period, owing to increasing prevalence of lifestyle-induced diseases and emergency department visits. According to the Centers of Disease Control and Prevention (CDC) report in 2017, around 1.7 million emergency department visits with chronic and unspecified bronchitis were recorded in the U.S.
Blood Gas Analyzers Market - Competitive Landscape
Key players operating in the global blood gas analyzers market include, Abbott Laboratories, Alere, Inc., Bayer AG, Dalko Diagnostics, GE Healthcare, Instrumentation Laboratory, Nova Biomedical, Radiometer, Roche Diagnostics, Siemens Healthcare, and Sphere Medical.
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Email: [email protected]